Treatment and clinical outcome of clinical T4 esophageal cancer: a systematic review
T Makino, M Yamasaki, K Tanaka… - Annals of …, 2019 - Wiley Online Library
Background Survival of patients with cT 4 esophageal cancer is dismal. Although the optimal
treatment strategy remains to be established, two treatment options are available for cT 4 …
treatment strategy remains to be established, two treatment options are available for cT 4 …
Treatment and clinical outcome of clinical T4 esophageal cancer: A systematic review
T Makino, M Yamasaki, K Tanaka… - Annals of …, 2019 - kyushu-u.elsevierpure.com
Background: Survival of patients with cT4 esophageal cancer is dismal. Although the optimal
treatment strategy remains to be established, two treatment options are available for cT4 …
treatment strategy remains to be established, two treatment options are available for cT4 …
[HTML][HTML] Treatment and clinical outcome of clinical T4 esophageal cancer: A systematic review
T Makino, M Yamasaki, K Tanaka… - Annals of …, 2019 - ncbi.nlm.nih.gov
Background Survival of patients with cT 4 esophageal cancer is dismal. Although the optimal
treatment strategy remains to be established, two treatment options are available for cT 4 …
treatment strategy remains to be established, two treatment options are available for cT 4 …
Treatment and clinical outcome of clinical T4 esophageal cancer: A systematic review
T Makino, M Yamasaki, K Tanaka, Y Miyazaki… - Annals of …, 2018 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: sec>< jats: title> Background</jats: title>< jats: p>
Survival of patients with< jats: styled-content style=" fixed-case"> cT</jats: styled-content> 4 …
Survival of patients with< jats: styled-content style=" fixed-case"> cT</jats: styled-content> 4 …
Treatment and clinical outcome of clinical T4 esophageal cancer: A systematic review
T Makino, M Yamasaki, K Tanaka… - Annals of …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Survival of patients with cT4 esophageal cancer is dismal. Although the optimal
treatment strategy remains to be established, two treatment options are available for cT4 …
treatment strategy remains to be established, two treatment options are available for cT4 …
Treatment and clinical outcome of clinical T4 esophageal cancer: A systematic review
T Makino, M Yamasaki, K Tanaka… - Annals of …, 2019 - search.proquest.com
Background Survival of patients with cT 4 esophageal cancer is dismal. Although the optimal
treatment strategy remains to be established, two treatment options are available for cT 4 …
treatment strategy remains to be established, two treatment options are available for cT 4 …
Treatment and clinical outcome of clinical T4 esophageal cancer: A systematic review.
T Makino, M Yamasaki, K Tanaka… - Annals of …, 2018 - europepmc.org
Background Survival of patients with cT4 esophageal cancer is dismal. Although the optimal
treatment strategy remains to be established, two treatment options are available for cT4 …
treatment strategy remains to be established, two treatment options are available for cT4 …
Treatment and clinical outcome of clinical T4 esophageal cancer: A systematic review.
T Makino, M Yamasaki, K Tanaka… - Annals of …, 2018 - europepmc.org
Background Survival of patients with cT4 esophageal cancer is dismal. Although the optimal
treatment strategy remains to be established, two treatment options are available for cT4 …
treatment strategy remains to be established, two treatment options are available for cT4 …